Sun Life publishes transcript of Q2 2026 earnings call webcast

SLF•2026-08-12

Sun Life’s Q2 2026 earnings call transcript detailed results with CEO Kevin Strain, CFO Tim Deacon, plus business heads for U.S., Asia, Canada, SLC.
Underlying net income was USD 1.12 billion, underlying EPS was USD 2.02; reported net income was USD 1.01 billion; LICAT ratio was 145%.
U.S. stop-loss sales rose 86%; management described Q2 morbidity pressure as expected IBNR seasonality; loss ratios stayed in the mid-70s.
Dental repositioning continued; Medicaid membership fell 9% on exits of unprofitable contracts; mix shift to commercial is expected over 1-2 years.
Asia sales rose 20% to USD 875 million; Hong Kong MCV represented about 30% of sales; new business CSM fell on competition-driven mix.

Sources

Docs